Grifols, S.A. (GIKLY) Q2 2026 Earnings Call Transcript
Grifols said the call will include forward-looking comments on operating performance, clinical developments and regulatory timelines, with a transcript posted within 24 hours.
7 Articles
7 Articles
El Periódico
Catalan pharmaceutical company involves €3.5 billion between January and June and earns €227 million net in the same period
The signature of blood products invoice 3.5 billion euros between January and June and earns 227 million euros net in this same period
Grifols earned 227 million euros in the first half of this year, 28.2% more than in the same period of the previous year. The Catalan multinational blood products company attributes the improvement, in large part, to the evolution of its biopharmaceuticals division, its main source of income. According to the results published this Tuesday to the National Securities Market Commission (CNMV), the turnover of this area reached 3,148 million euros …
Coverage Details
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
